RecruitingNCT06531681

Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)

The Second Affiliated Hospital of Hainan Medical University

Sponsor

The Second Affiliated Hospital of Hainan Medical University

Enrollment

3,000 participants

Start Date

Aug 19, 2023

Study Type

OBSERVATIONAL

Conditions

Quality of Life Oncology Radiation Toxicity Overall Response Rate

Summary

Aim to observe the application of MR-Linac for precision radiotherapy of tumours, analyse its therapeutic effect, toxic and side effects,Characteristics of dosimetric parameters etc.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria4

Patients are undergoing or have undergone imaging or treatment at the MR linac;
Age 18-75 years, male or female;
ECOG score 0-2, life expectancy > 6 months;
Patients provide written informed consent.

Exclusion Criteria5

Contraindications to MRI, such as claustrophobia and metallic or electronic implants incompatible with MRI;
The presence of severe comorbidities that, in the opinion of the investigator, · preclude the toleration or completion of radiotherapy;
Acute inflammatory disease requiring systemic therapy;
The presence of active infectious disease;
Pregnant women, nursing mothers, and patients planning to have children during the study period.

Interested in this trial?

Get notified about updates and connect with the research team.